RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Regulatory Update

Regulatory Update

Posted 01 October 2011 | By Michael Matthews 

The use of foreign reviews in Health Canada has always been considered, but has only happened on an ad hoc basis and has not been consistent. On 9 September 2011, Health Canada released draft guidance for consultation for the use of foreign reviews in marketing applications. The guidance clarifies for applicants the way Health Canada will use foreign reviews for marketing authorization. Nonetheless, a Canadian marketing application must still contain all of the necessary information and materials normally submitted.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.